the verify trial: rusfertide in patients with polycythemia vera
Published 1 month ago • 92 plays • Length 1:30Download video MP4
Download video MP3
Similar videos
-
1:56
rationale for verify: rusfertide added to ongoing therapy in patients with polycythemia vera
-
2:08
phase iii trial of rusfertide in patients with polycythemia vera
-
5:42
an update on revive: rusfertide in patients with polycythemia vera
-
3:23
the role of rusfertide in polycythemia vera
-
1:12
contemporary challenges in polycythemia vera management
-
9:07
revive: targeted therapy for uncontrolled erythrocytosis in pv with rusfertide
-
5:00
long-term results of the phase ii revive study evaluating rusfertide in patients with pv
-
2:16
determining when to switch from hydroxyurea to interferon-based therapy in patients with pv
-
3:10
promising trials in polycythemia vera
-
3:07
the current treatment algorithm for polycythemia vera
-
1:39
upcoming agents in et and pv
-
5:56
rusfertide reduces need for therapeutic phlebotomy in pv patients
-
2:54
an update on the use of idasanutlin in polycythemia vera
-
3:10
the stories behind the advances in polycythemia vera
-
1:34
are thrombotic risk and progression in et predictable?
-
3:59
pv: outcomes, unmet needs, and therapeutic strategies
-
1:52
cytoreductive therapy for patients with pv
-
3:05
recent updates in the mpn field: clinical trials, novel agents, and more
-
2:14
risk-adapted treatment of et & pv